Skip to Content

Reshape Lifesciences Inc RSLS

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. Its operating segments include the Lap-Band and ReShape Vest. The company's current portfolio includes the LAP-BAND Adjustable Gastric Banding System and the ReShape VestTM, an investigational device, to help treat more patients with obesity.

Contact
1001 Calle Amanecer
San Clemente, CA, 92673
T +1 949 429-6680
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type Speculative Growth
Employees 38